Browse Category

Analyst Ratings News 2 December 2025 - 3 December 2025

GitLab (GTLB) Stock on December 3, 2025: 14% Post‑Earnings Selloff, Analyst Target Cuts and AI‑Driven Growth Story

GitLab (GTLB) Stock on December 3, 2025: 14% Post‑Earnings Selloff, Analyst Target Cuts and AI‑Driven Growth Story

GitLab Inc. (NASDAQ: GTLB) shares are under heavy pressure on December 3, 2025, as investors digest the company’s latest quarterly results, cautious guidance, and a wave of fresh analyst reactions. After reporting fiscal Q3 2026 (quarter ended October 31, 2025)
Stellantis (STLA) Stock Jumps on UBS Upgrade and US Hiring Spree – Key News, Forecasts and Risks on December 3, 2025

Stellantis (STLA) Stock Jumps on UBS Upgrade and US Hiring Spree – Key News, Forecasts and Risks on December 3, 2025

Stellantis N.V. (NYSE: STLA) is back in the market spotlight. On December 3, 2025, the automaker’s shares are rallying in Europe and the US after a high‑profile analyst upgrade, fresh details on its American growth push, and a controversial class‑action
Capricor Therapeutics (CAPR) Soars on Positive Phase 3 HOPE‑3 Results: Latest Stock News, Analyst Targets and 2025 Outlook

Capricor Therapeutics (CAPR) Soars on Positive Phase 3 HOPE‑3 Results: Latest Stock News, Analyst Targets and 2025 Outlook

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is back in the spotlight on December 3, 2025, after announcing positive topline results from its pivotal Phase 3 HOPE‑3 trial of deramiocel (CAP‑1002) in Duchenne muscular dystrophy (DMD). The news has reignited hopes for
Go toTop